Precigen, Inc. NASDAQ:PGEN

Precigen stock price today

$3.1
+2.37
+326.82%
Financial Health
0
1
2
3
4
5
6
7
8
9

Precigen stock price monthly change

-54.91%
month

Precigen stock price quarterly change

-54.91%
quarter

Precigen stock price yearly change

-48.14%
year

Precigen key metrics

Market Cap
221.23M
Enterprise value
248.92M
P/E
-2.81
EV/Sales
4.66
EV/EBITDA
5.44
Price/Sales
3.78
Price/Book
1.60
PEG ratio
-0.18
EPS
0.04
Revenue
20.78M
EBITDA
-70.79M
Income
10.26M
Revenue Q/Q
-42.46%
Revenue Y/Y
-10.60%
Profit margin
53.01%
Oper. margin
-131.7%
Gross margin
59.29%
EBIT margin
-131.7%
EBITDA margin
-340.64%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Precigen stock price history

Precigen stock forecast

Precigen financial statements

Precigen, Inc. (NASDAQ:PGEN): Profit margin
Jun 2023 1.76M -20.31M -1149.92%
Sep 2023 16.72M 87.37M 522.54%
Dec 2023 1.22M -33.05M -2691.86%
Mar 2024 1.06M -23.73M -2228.92%
Precigen, Inc. (NASDAQ:PGEN): Analyst Estimates
Dec 2023 1.22M -33.05M -2691.86%
Mar 2024 1.06M -23.73M -2228.92%
Sep 2025 29.4M -7.47M -25.43%
Dec 2025 35.7M -4.98M -13.96%
  • Analysts Price target

  • Financials & Ratios estimates

Precigen, Inc. (NASDAQ:PGEN): Debt to assets
Jun 2023 207527000 41.31M 19.91%
Sep 2023 190688000 43.01M 22.56%
Dec 2023 151043000 41.64M 27.57%
Mar 2024 134847000 37.82M 28.05%
Precigen, Inc. (NASDAQ:PGEN): Cash Flow
Jun 2023 -15.76M 23.50M -14.58M
Sep 2023 -17.00M 10.52M -120K
Dec 2023 -15.76M 13.29M -11K
Mar 2024 -14.09M 24.04M 0

Precigen alternative data

Precigen, Inc. (NASDAQ:PGEN): Employee count
Sep 2023 209
Oct 2023 209
Nov 2023 209
Dec 2023 209
Jan 2024 209
Feb 2024 209
Mar 2024 202
Apr 2024 202
May 2024 202
Jun 2024 202
Jul 2024 202

Precigen other data

14.03% -7.03%
of PGEN is owned by hedge funds
28.11M -14.15M
shares is hold by hedge funds

Precigen, Inc. (NASDAQ:PGEN): Insider trades (number of shares)
Period Buy Sel
Jan 2023 11517712 0
Aug 2023 1470345 359020
Sep 2023 25000 0
Dec 2023 96686 96686
Transaction Date Insider Security Shares Price per share Total value Source
Option
THOMASIAN HARRY JR. officer: Chief Financial Officer
Common Stock 135,714 N/A N/A
Option
THOMASIAN HARRY JR. officer: Chief Financial Officer
Restricted Stock Units 135,714 N/A N/A
Option
PEREZ JEFFREY THOMAS officer: SVP, IP .. Common Stock 142,857 N/A N/A
Option
PEREZ JEFFREY THOMAS officer: SVP, IP .. Restricted Stock Units 142,857 N/A N/A
Option
SABZEVARI HELEN director, officer: President an..
Common Stock 1,071,429 N/A N/A
Option
SABZEVARI HELEN director, officer: President an..
Restricted Stock Units 1,071,429 N/A N/A
Option
SHAH RUTUL R officer: Chief Operating Officer
Common Stock 117,142 N/A N/A
Option
SHAH RUTUL R officer: Chief Operating Officer
Restricted Stock Units 117,142 N/A N/A
Option
LEHR DONALD P. officer: Chief Le.. Common Stock 164,285 N/A N/A
Option
LEHR DONALD P. officer: Chief Le.. Restricted Stock Units 164,285 N/A N/A
Patent
Application
Filling date: 4 Feb 2022 Issue date: 19 May 2022
Application
Filling date: 4 Feb 2022 Issue date: 19 May 2022
Grant
Filling date: 4 Jun 2019 Issue date: 3 May 2022
Application
Filling date: 8 Nov 2021 Issue date: 14 Apr 2022
Application
Filling date: 13 Sep 2021 Issue date: 3 Mar 2022
Application
Filling date: 11 Jun 2021 Issue date: 3 Mar 2022
Application
Filling date: 31 Jul 2021 Issue date: 17 Feb 2022
Application
Filling date: 27 Jun 2019 Issue date: 23 Dec 2021
Grant
Filling date: 11 May 2018 Issue date: 26 Oct 2021
Application
Filling date: 5 May 2021 Issue date: 21 Oct 2021
Insider Compensation
Dr. Helen Sabzevari MPH, Ph.D. (1962) Pres, Chief Executive Officer & Director
$1,770,000
Mr. Donald P. Lehr (1975) Chief Legal Officer & Corporation Sec. $808,210
Mr. Jeffrey Thomas Perez (1972) Senior Vice President of Intellectual Property Affairs $705,720
Friday, 27 December 2024
prnewswire.com
Thursday, 14 November 2024
zacks.com
prnewswire.com
Tuesday, 12 November 2024
prnewswire.com
Monday, 16 September 2024
prnewswire.com
Sunday, 15 September 2024
247wallst.com
Friday, 30 August 2024
247wallst.com
Thursday, 15 August 2024
benzinga.com
Wednesday, 14 August 2024
seekingalpha.com
zacks.com
prnewswire.com
Friday, 9 August 2024
prnewswire.com
Wednesday, 7 August 2024
prnewswire.com
zacks.com
Tuesday, 6 August 2024
prnewswire.com
prnewswire.com
Tuesday, 23 July 2024
prnewswire.com
Monday, 3 June 2024
prnewswire.com
Thursday, 23 May 2024
prnewswire.com
Tuesday, 14 May 2024
Zacks Investment Research
Friday, 19 January 2024
Seeking Alpha
Monday, 18 December 2023
PRNewsWire
Monday, 4 December 2023
InvestorPlace
Wednesday, 22 November 2023
InvestorPlace
Tuesday, 5 September 2023
Zacks Investment Research
Thursday, 17 August 2023
PennyStocks
Wednesday, 9 August 2023
Seeking Alpha
Friday, 19 May 2023
InvestorPlace
Thursday, 4 May 2023
InvestorPlace
Wednesday, 3 May 2023
PRNewsWire
  • What's the price of Precigen stock today?

    One share of Precigen stock can currently be purchased for approximately $3.1.

  • When is Precigen's next earnings date?

    Unfortunately, Precigen's (PGEN) next earnings date is currently unknown.

  • Does Precigen pay dividends?

    No, Precigen does not pay dividends.

  • How much money does Precigen make?

    Precigen has a market capitalization of 221.23M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 76.87% to 6.23M US dollars.

  • What is Precigen's stock symbol?

    Precigen, Inc. is traded on the NASDAQ under the ticker symbol "PGEN".

  • What is Precigen's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Precigen?

    Shares of Precigen can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Precigen's key executives?

    Precigen's management team includes the following people:

    • Dr. Helen Sabzevari MPH, Ph.D. Pres, Chief Executive Officer & Director(age: 63, pay: $1,770,000)
    • Mr. Donald P. Lehr Chief Legal Officer & Corporation Sec.(age: 50, pay: $808,210)
    • Mr. Jeffrey Thomas Perez Senior Vice President of Intellectual Property Affairs(age: 53, pay: $705,720)
  • How many employees does Precigen have?

    As Jul 2024, Precigen employs 202 workers.

  • When Precigen went public?

    Precigen, Inc. is publicly traded company for more then 12 years since IPO on 8 Aug 2013.

  • What is Precigen's official website?

    The official website for Precigen is precigen.com.

  • Where are Precigen's headquarters?

    Precigen is headquartered at 20374 Seneca Meadows Parkway, Germantown, MD.

  • How can i contact Precigen?

    Precigen's mailing address is 20374 Seneca Meadows Parkway, Germantown, MD and company can be reached via phone at +30 15569900.

Precigen company profile:

Precigen, Inc.

precigen.com
Exchange:

NASDAQ

Full time employees:

202

Industry:

Biotechnology

Sector:

Healthcare

Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorporates advanced DNA construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbIL15, a gene that enhances functional characteristics of immune cells; Sleeping Beauty, a non-viral transposon/transposase system; AttSite recombinases, which breaks and rejoins DNA at specific sequences; AdenoVerse technology platform, a library of engineered adenovector serotypes; and L. lactis is a food-grade bacterium. Additionally, it provides RheoSwitch, an inducible gene switch system that provides quantitative dose-proportionate regulation of the amount and timing of target protein expression; kill switches to selectively eliminate cell therapies in vivo; tissue-specific promoters; UltraCAR-T platform for the treatment of cancer; AdenoVerse Immunotherapy, a library of proprietary adenovectors for the gene delivery; and ActoBiotics platform, genetically modified bacteria that deliver proteins and peptides at mucosal sites. Precigen, Inc. has collaboration and license agreements with Alaunos Therapeutics, Inc.; Ares Trading S.A.; Oragenics, Inc.; Castle Creek Biosciences, Inc.; Intrexon Energy Partners, LLC; and Intrexon Energy Partners II, LLC. The company was formerly known as Intrexon Corporation and changed its name to Precigen, Inc. in January 2020. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland.

20374 Seneca Meadows Parkway
Germantown, MD 20876

CIK: 0001356090
ISIN: US74017N1054
CUSIP: 74017N105